Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county ,
The risk of colorectal cancer in ulcerative colitis: a meta-analysis, Gut, vol.48, issue.4, pp.526-561, 2001. ,
DOI : 10.1136/gut.48.4.526
Thirty-Year Analysis of a Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis, Gastroenterology, vol.130, issue.4, pp.1030-1038, 2006. ,
DOI : 10.1053/j.gastro.2005.12.035
Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies, Clinical Gastroenterology and Hepatology, vol.10, issue.6, pp.639-684, 2012. ,
DOI : 10.1016/j.cgh.2012.01.010
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations J Crohns Colitis, 2012. ,
High lifetime risk of cancer in primary sclerosing cholangitis, Journal of Hepatology, vol.50, issue.1, pp.158-64, 2009. ,
DOI : 10.1016/j.jhep.2008.08.013
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis, Gastroenterology, vol.126, issue.2, pp.451-460, 2004. ,
DOI : 10.1053/j.gastro.2003.11.010
Familial predisposition for colorectal cancer in chronic ulcerative colitis: A case-control study, Gastroenterology, vol.115, issue.5 ,
DOI : 10.1016/S0016-5085(98)70077-0
Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case ?control study, Gastroenterology, vol.130, pp.1941-1950, 2006. ,
Effect of 5-Aminosalicylate Use on Colorectal Cancer and Dysplasia Risk: A Systematic Review and Metaanalysis of Observational Studies, The American Journal of Gastroenterology, vol.18, issue.2, pp.1345-53, 2005. ,
DOI : 10.1097/00054725-200401000-00003
5-Aminosalicylic Acid Is Not Protective Against Colorectal Cancer in Inflammatory Bowel Disease: A Meta-Analysis of Non-Referral Populations, The American Journal of Gastroenterology, vol.107, issue.9, pp.1298-304, 2012. ,
DOI : 10.1053/j.gastro.2010.02.007
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis, Gastroenterology, vol.124, issue.4 ,
DOI : 10.1053/gast.2003.50156
Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease, Gastroenterology, vol.141, issue.5, pp.1621-1629, 2011. ,
DOI : 10.1053/j.gastro.2011.06.050
URL : https://hal.archives-ouvertes.fr/hal-00631539
Colorectal cancer in inflammatory bowel diseases: A population-based study, Inflamm Bowel Dis, vol.18, pp.2241-51, 1976. ,
Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis, Lancet, vol.343, pp.71-75, 1994. ,
Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis, Gastroenterology, vol.125, issue.5, pp.1311-1320, 2003. ,
DOI : 10.1016/j.gastro.2003.08.023
Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis, Alimentary Pharmacology & Therapeutics, vol.43, issue.2, pp.657-68, 2007. ,
DOI : 10.1016/0016-5085(92)91163-X
Increased Risk of Intestinal Cancer in Crohn's Disease: A Meta-Analysis of Population-Based Cohort Studies, The American Journal of Gastroenterology, vol.107, issue.2, pp.2724-2733, 2005. ,
DOI : 10.1111/j.1572-0241.2003.08671.x
AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease, Gastroenterology, vol.138, pp.738-783, 2010. ,
European Crohn's and Colitis Organisation (ECCO) European evidence-based Consensus on the management of ulcerative colitis: Special situations, J ,
Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease, Gut, vol.60, issue.7, pp.930-936, 2011. ,
DOI : 10.1136/gut.2010.227884
The rating form of IBD patient concerns: a new measure of health status., Psychosomatic Medicine, vol.53, issue.6, pp.701-713, 1991. ,
DOI : 10.1097/00006842-199111000-00010
Cancer Surveillance in Ulcerative Colitis: A Survey of Patients' Knowledge, Endoscopy, vol.28, issue.09, pp.761-763, 1996. ,
DOI : 10.1055/s-2007-1005601
Screening patients with a family history of colorectal cancer, J Gen Intern Med, vol.22, pp.508-521, 2007. ,
Information needs and preferences of recently diagnosed patients with inflammatory bowel disease ,
Communication of information to patients with inflammatory bowel disease: A European Collaborative Study in a multinational prospective inception cohort, Journal of Crohn's and Colitis, vol.94, issue.Suppl, pp.226-258, 2008. ,
DOI : 10.1111/j.1572-0241.1999.01536.x
A Systematic Review of Patient Inflammatory Bowel Disease Information Resources on the World Wide Web, The American Journal of Gastroenterology, vol.72, issue.9, pp.2070-2077, 2007. ,
DOI : 10.1016/S0022-5347(05)00996-1
Quality of web-based information on inflammatory bowel diseases, Inflammatory Bowel Diseases, vol.102, issue.12, pp.1891-1897, 2009. ,
DOI : 10.1111/j.1572-0241.2007.01325.x
How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance, Gastrointestinal Endoscopy, vol.51, issue.2, pp.123-131, 2000. ,
DOI : 10.1016/S0016-5107(00)70405-6
Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn???s colitis patients in the Netherlands, World Journal of Gastroenterology, vol.15, issue.2, pp.226-256, 2009. ,
DOI : 10.3748/wjg.15.226
Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity, Inflamm Bowel Dis, vol.17, pp.1759-68, 2011. ,
IIeal Pouch-Anal Anastomoses Complications and Function in 1005 Patients, Annals of Surgery, vol.222, issue.2, pp.120-127, 1995. ,
DOI : 10.1097/00000658-199508000-00003
Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis, The American Journal of Gastroenterology, vol.8, issue.10, pp.2929-2962, 2001. ,
DOI : 10.1046/j.1365-2036.2000.00698.x
The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review, Alimentary Pharmacology and Therapeutics, vol.133, issue.1 ,
DOI : 10.1016/S0022-3476(98)70187-8
REFERENCES 1 Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Aliment Pharmacol Ther Minnesota. Gastoenterology, vol.16130, pp.51-601039, 2002. ,
Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies, Clinical Gastroenterology and Hepatology, vol.10, issue.6, pp.639-645, 2012. ,
DOI : 10.1016/j.cgh.2012.01.010
European evidence-based Consensus on the management of ulcerative colitis: Special situations, Journal of Crohn's and Colitis, vol.23, issue.Suppl II, pp.63-92, 2008. ,
DOI : 10.1111/j.1365-2036.2006.02761.x
Effect of 5-Aminosalicylate Use on Colorectal Cancer and Dysplasia Risk: A Systematic Review and Metaanalysis of Observational Studies, The American Journal of Gastroenterology, vol.18, issue.2, pp.1345-1353, 2005. ,
DOI : 10.1097/00054725-200401000-00003
5-aminosalicylic Acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populations ,
Increased Risk of Intestinal Cancer in Crohn's Disease: A Meta-Analysis of Population-Based Cohort Studies, The American Journal of Gastroenterology, vol.107, issue.2, pp.2724-2729, 2005. ,
DOI : 10.1111/j.1572-0241.2003.08671.x
Colorectal cancer in inflammatory bowel diseases: A population-based study Inflamm Bowel Dis, 1976. ,